MUMBAI (Reuters) - Serum Institute of India has put trials of AstraZeneca's COVID-19 vaccine candidate on hold until the British drugmaker restarts the trials, Serum said on Thursday.
"We are reviewing the situation and pausing India trials," Serum said in a brief statement.
AstraZeneca said on Tuesday it had paused trials of its experimental coronavirus vaccine because of an unexplained illness in a study participant, but its partner Serum had at the time said its trials in India were still ongoing.
(Reporting by Euan Rocha in Mumbai; Additional reporting by Sachin Ravikumar in Bengaluru; Editing by Shounak Dasgupta)
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)